Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:58 PM
Ignite Modification Date: 2025-12-24 @ 11:58 PM
NCT ID: NCT02385058
Eligibility Criteria: Inclusion Criteria: * Minors whose parents or tutor grant his/her informed consent in writing to participate in the study. Adult participants that give their informed consent in writing to participate * Participants having a copro-parasitoscopy test (scatology) (at least 1 with a series of 3) qualitative and quantitative and/or search of live amoeba, that comes out positive for one or more of the following parasites: Ascaris lumbricoides, Enterobius vermicularis, Trichuris trichuria, Taenia solium, Necator americanus, Ancylostoma duodenale and Trophozoites of Entamoeba histolytica * With at least two or more of the following symptoms: Anorexia, Nausea, Vomit, Abdominal pain, Diarrhea, Constipation, Evacuations with mucus, Evacuations with blood, Gas discharge, Weight loss and Bruxism Exclusion Criteria: * Participants with any known allergy to any of the drugs used in the investigation * Female Participant in reproductive age not using an adequate contraceptive method * Pregnant or lactating Participant * Participant with any life-threatening condition (cancer, AIDS, etc.) * Participant known to be a carrier of some illness that alters the metabolism or drug excretion (hepatic or renal illness) interfering with the absorption (malabsorption) or interferes with the evaluation of the Participant during the study * Participants that have taken any antiparasitic drug 14 days previous to his/her inclusion in this clinical investigation protocol * Participants with diagnosis of extra-intestinal amoebiasis
Healthy Volunteers: False
Sex: ALL
Minimum Age: 10 Years
Maximum Age: 75 Years
Study: NCT02385058
Study Brief:
Protocol Section: NCT02385058